The startup develops a non-invasive injectable viscous gel designed to restore the natural biomechanics of the spine, specifically targeting the underlying causes of lower back pain. This therapy provides patients with a treatment option that alleviates discomfort and improves spinal function.
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic orthopedic conditions affect over a billion people globally and are a leading cause of disability. Current treatments primarily focus on pain management without addressing the underlying tissue damage, often leading to invasive surgeries as a last resort.
Solution
NC Biomatrix is developing an injectable technology designed to trigger the native regenerative mechanisms of cartilage tissues. Their approach aims to restore the natural biomechanics of the spine and other orthopedic structures by addressing the root cause of the condition, rather than merely alleviating symptoms. The technology utilizes a viscous gel that is injected non-invasively to promote tissue restoration. This offers a potential alternative to destructive, high-risk surgical interventions.
Target Audience
The primary target audience includes individuals suffering from chronic orthopedic conditions, as well as orthopedic surgeons and medical professionals seeking alternative treatment options to traditional pain management and invasive surgeries.
Features
- Non-invasive injectable viscous gel for targeted delivery
- Designed to stimulate native regenerative mechanisms in cartilage tissues
- Aims to restore natural biomechanics in the spine and other orthopedic structures